TEL-AVIV, Israel, Nov. 28, 2017 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (CNBX) announced today that it has received a new research license from the Israeli Ministry of Health for the Characterization of anti-tumor activity of cannabinoids . The new license will enable the company to continue … Read More
The post Cannabics Pharmaceuticals Received a New Research License for Characterization of Anti-Tumor … appeared first on Dagga Magazine.